Gut dysbiosis during COVID-19 and probiotics

Gut dysbiosis during COVID-19 and probiotics

Some people infected with COVID-19 have reported gastrointestinal (GI) inflammation, with presentations ranging from cramps to complications with intestinal perforations. However, there’s a lack of research detailing successful treatment options for COVID-19 patients experiencing GI problems.

A recent paper published in July 2021 investigated gut dysbiosis during COVID-19 infection, as well as the therapeutic effects of probiotics. At the time of the review, there were 19 clinical trials underway looking at probiotics and their role in COVID-19 patients. Once published, it’s hoped that these will help to identify whether there’s a preventative or therapeutic role of probiotics for COVID-19 patients.

If you’d like to receive more content like this.

Other content you might be interested in

Dr Lynne Anne Barker gut microbiome and neurological health

The gut microbiome and its role in neurological health by Dr Lynne Anne Barker

Associate Professor in cognitive neuroscience, Behavioural Science and Applied Psychology, Sheffield Hallam University,

Gut-brain axis

An inspirational woman in science

by Sian Shepherd, BSc (Hons) Nutrition
Registered NHS & Freelance Dietitian, specialising in Gastroenterology

Probiotics and Eczema

by Sian Shepherd, BSc (Hons) Nutrition
Registered NHS & Freelance Dietitian, specialising in Gastroenterology

Copyright © Symprove™